Syncordia Technologies and Healthcare Solutions, Corp. to Host Second Quarter 2017 Investor Conference Call on November 24, 2016
- Company to issue second quarter 2017 press release on Wednesday, November 23, 2016 after market close
- Company to hold conference call on Thursday, November 24, 2016 at 8:00 a.m. ET
TORONTO, Nov. 22, 2016 /CNW/ - Syncordia Technologies and Healthcare Solutions, Corp. (TSXV: SYN) ("Syncordia" or the "Company") today announced that it will be reporting its second quarter fiscal 2017 results after markets close on Wednesday November 23, 2016 and will be hosting a conference call on Thursday, November 24, 2016 at 8:00 a.m. ET. The call will be hosted by Michael Franks, Chief Executive Officer and Adam Fabian, Corporate Controller. All interested parties are invited to participate.
In addition, the Company will post a presentation of the Q2 fiscal 2017 results on its website at:
http://www.syncordiahealth.com/company/investor-relations/events-presentations/
CONFERENCE CALL DETAILS:
DATE: |
Thursday, November 24, 2016 |
TIME: |
8:00 a.m. ET |
DIAL IN NUMBER: |
647-427-7450 or 1-888-231-8191 |
TAPED REPLAY: |
416-849-0833 or 1-855-859-2056 |
Available until 12:00 midnight (ET) Thursday, December 1, 2016 |
|
Reference number: 17957707 |
|
LIVE WEBCAST: |
http://event.on24.com/r.htm?e=1309987&s=1&k=924601BCAA1A9D2932324974BAA379A5 |
Webcast will be archived for 90 days |
About Syncordia Technologies and Healthcare Solutions, Corp.
We are a technology enhanced revenue cycle management ("RCM") company focused on underserved niche segments of the healthcare industry. We are building a diversified software and services business by consolidating healthcare billing providers. Our growth strategy is to acquire RCM businesses with and without software and improve their profitability by increasing revenues and operating efficiencies using our software, and in time, commercializing Platform Syncordia, our cloud-based software offering, to provide customer demanded turn-key solutions from a single provider and to address compelling RCM market opportunities
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Syncordia Technologies and Healthcare Solutions, Corp.
Michael Franks, Chief Executive Officer, (647) 949-2663, [email protected]
Share this article